4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-040662
Chief Medical Officer sold 12,500 shares at an average $37.78 ($472,252)
- Chief Medical Officer acquired 12,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Pang Phillip Chief Medical Officer | 2020-07-01 | Option exercise | +2,778 | $1.58 | $4,375 | 18,555 | D |
| Pang Phillip Chief Medical Officer | 2020-07-01 | Option exercise | +9,722 | $5.18 | $50,311 | 28,277 | D |
| Pang Phillip Chief Medical Officer | 2020-07-01 | Sale | −7,500 | $37.79 | $283,412 | 23,277 | D |
| Pang Phillip Chief Medical Officer | 2020-07-01 | Sale | −5,000 | $37.77 | $188,841 | 15,777 | D |
| Derivatives | |||||||
| Pang Phillip Chief Medical Officer | 2020-07-01 | Option exercise · Employee Stock Option (Right to Buy) | −2,778 | 108,333 | D | ||
| Pang Phillip Chief Medical Officer | 2020-07-01 | Option exercise · Employee Stock Option (Right to Buy) | −9,722 | 76,338 | D | ||
| Open-market sales · 12,500 sh · avg $37.78 · $472,252 | |||||||
Loading xslF345X03/doc4.xml…